BLOODOMICS LTD

Executive Summary

Bloodomics Ltd is a newly formed micro-entity with a strong liquidity position and no regulatory compliance issues to date. However, the limited operational history and concentrated ownership warrant further examination to confirm business sustainability and governance robustness. Overall, the financial data suggests low immediate risk but requires ongoing monitoring as the company matures.

BLOODOMICS LTD - Analysis Report

Company Number: 14720234

Analysis Date: 2025-07-29 17:16 UTC

1. Risk Rating: LOW
   The company is newly incorporated (March 2023) with a micro-entity reporting status, showing positive net current assets and no overdue filings. The modest current assets relative to current liabilities provide a comfortable short-term liquidity position. No indications of distress or regulatory non-compliance are evident.

2. Key Concerns:

• Limited operational history: The company has less than two years of financial data, which limits trend analysis and assessment of business sustainability.
• Concentration of control: One individual (Dr. Nicholas Stephen Gleadall) holds 75-100% ownership and voting rights, which may present governance and succession risks.
• Small scale and resources: Being a micro-entity with only three employees may constrain growth potential and operational resilience.

3. Positive Indicators:

• Strong liquidity position with net current assets of £39,219 against current liabilities of £9,830.
• Compliance with filing requirements: No overdue accounts or confirmation statements, indicating good regulatory discipline.
• Presence of directors with relevant professional backgrounds (computer programming and medicine) aligned with the IT consultancy SIC code.

4. Due Diligence Notes:

• Verify the nature and sustainability of revenue streams and business model given the early stage and limited financial history.
• Review any contractual obligations or contingent liabilities not reflected in the balance sheet.
• Assess the corporate governance framework given the ownership concentration and whether any minority interests or external investors exist.